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Abstract: In human addicts, drug relapse and craving are often provoked by 
stress. Since 1995, this clinical scenario has been studied using a rat model of 
stress-induced reinstatement of drug seeking. Here, we first discuss the 
generality of stress-induced reinstatement to different drugs of abuse, 
different stressors, and different behavioral procedures. We also discuss 
neuropharmacological mechanisms, and brain areas and circuits controlling 
stress-induced reinstatement of drug seeking. We conclude by discussing 
results from translational human laboratory studies and clinical trials that 
were inspired by results from rat studies on stress-induced reinstatement. 
Our main conclusions are (1) The phenomenon of stress-induced 
reinstatement, first shown with an intermittent footshock stressor in rats 
trained to self-administer heroin, generalizes to other abused drugs, including 
cocaine, methamphetamine, nicotine, and alcohol, and is also observed in the 
conditioned place preference model in rats and mice. This phenomenon, 
however, is stressor specific and not all stressors induce reinstatement of 
drug seeking. (2) Neuropharmacological studies indicate the involvement of 
corticotropin-releasing factor (CRF), noradrenaline, dopamine, glutamate, 
kappa/dynorphin, and several other peptide and neurotransmitter systems in 
stress-induced reinstatement. Neuropharmacology and circuitry studies 
indicate the involvement of CRF and noradrenaline transmission in bed 
nucleus of stria terminalis and central amygdala, and dopamine, CRF, 
kappa/dynorphin, and glutamate transmission in other components of the 
mesocorticolimbic dopamine system (ventral tegmental area, medial 
prefrontal cortex, orbitofrontal cortex, and nucleus accumbens). (3) 
Translational human laboratory studies and a recent clinical trial study show 
the efficacy of alpha-2 adrenoceptor agonists in decreasing stress-induced 
drug craving and stress-induced initial heroin lapse. 
Introduction 
A central feature of drug addiction is the high rate of relapse 
during abstinence (Hunt et al, 1971; O'Brien, 2005). Over the years, 
results from many correlational human studies have suggested that 
this relapse is often provoked by stress (Box 1) (Khantzian, 1985; 
Shiffman and Wills, 1985; Kosten et al, 1986). These clinical studies 
have led to the development of a rat model, which is based on the 
operant conditioning reinstatement model (Stewart and de Wit, 1987), 
to study mechanisms of stress-induced relapse to drug seeking 
(Shaham et al, 2000a). In the reinstatement model, laboratory 
animals are tested for reinstatement of drug seeking induced by drug 
priming, discrete cues, discriminative cues, contextual cues, or 
stressors, following drug self-administration training (typically lever 
pressing or nose poking for drug infusions) and subsequent extinction 
of the drug-reinforced responding (Shaham et al, 2003; Stewart and 
de Wit, 1987). The first study using the reinstatement model was 
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published in 1995 using male and female rats that were trained to self-
administer heroin for 12 days for 12 h/day. In this study, acute 
exposure to 10 min of intermittent footshock stress immediately before 
the test sessions reinstated heroin seeking after 1–2 weeks of 
extinction training and after an additional 4- to 6-week drug-free 
period (Shaham and Stewart, 1995) (Figure 1). 
 
Figure 1. Effect of intermittent footshock stress on reinstatement across drug classes. 
Data are mean±SEM non-reinforced active lever presses after exposure to intermittent 
footshock or no shock immediately before the reinstatement tests in rats with a 
history of heroin, cocaine, alcohol, nicotine, or methamphetamine self-administration. 
The session duration was 3 h for heroin and cocaine, 1 h for alcohol and nicotine, and 
2 h for methamphetamine. The intermittent footshock (0.5 s ON; mean inter-shock-
interval 40 s) duration was 10 min for heroin and cocaine, 5 min for alcohol and 
methamphetamine, and 15 min for nicotine. Data were redrawn from Buczek et al 
(1999), Erb et al (1996), Le et al (1998), Shaham and Stewart (1995), and Shepard 
et al (2004). *Different from the no stress condition, p<0.05. 
Box 1. The Stress Concept 
Stress is a complex psychological construct that despite many 
decades of research (Cannon, 1935; Selye, 1936) lacks a singular 
operational definition (Chrousos and Gold, 1992; Cohen et al, 1982). 
In animal models of psychiatric disorders, stress can be broadly 
defined as forced exposure to events or conditions that are normally 
avoided (Piazza and Le Moal, 1998). In humans, the stress definition is 
often extended to incorporate cognitive and emotional responses as 
suggested by Cohen et al (1986): ‘stress is a condition in which the 
environmental demands exceed the coping abilities of the individual.' 
In laboratory animals, the precipitating events or conditions can be 
divided into two main categories (Lu et al, 2003). The first includes 
aversive conditions like restraint, footshock, tail pinch, social defeat, or 
pharmacological stressors like exogenous CRF that the rat would avoid 
if given the opportunity. The second includes conditions like food 
deprivation, social isolation, or maternal deprivation; each consists of 
the removal of an environmental condition that is important for 
maintaining the animal's normal steady-state conditions, a state that 
the subject will attempt to ameliorate by seeking food, conspecific 
partners, or the dam. 
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In this review, we summarize results from studies published 
during the last 20 years in which investigators have used different 
variations of the stress-induced reinstatement model to study 
behavioral, neuropharmacological, and neuroanatomical mechanisms 
of stress-induced reinstatement of drug seeking. We also summarize 
results from human studies that have determined the degree to which 
the results from the preclinical studies ‘translate' to the human 
condition. The material in our review overlaps to some degree with 
previous reviews (Bossert et al, 2005, 2013; Lu et al, 2003; Mantsch 
et al, 2014; Shaham et al, 2003; Shalev et al, 2010, 2002; Sinha et 
al, 2011b), but provides the only comprehensive review uniquely 
dedicated to the phenomenon of stress-induced reinstatement across 
drug classes since an early review in 2000 (Shaham et al, 2000a). 
Since 1995, over 200 papers have been published on this phenomenon 
(PubMed, Figure 2). Due to space limitations, we do not cover all 
published papers on this topic in our review. 
 
Figure 2. Publications on stress-induced reinstatement. Number of preclinical 
publications per 5-year period on stress-induced reinstatement of drug self-
administration and CPP since 1995. 
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Generality of Stress-Induced Reinstatement 
Generality to Other Drug and Non-Drug Rewards 
Early studies showed that the effect of intermittent footshock on 
reinstatement of heroin seeking generalized to male rats with a history 
of cocaine (Erb et al, 1996), alcohol (Le et al, 1998), nicotine (Buczek 
et al, 1999), and methamphetamine (Shepard et al, 2004) self-
administration (Figure 1). In contrast, several early studies showed 
that exposure to an intermittent footshock stressor that reinstates 
drug seeking (Shaham et al, 2000a) does not reinstate food reward 
seeking in male rats trained to self-administer food pellets (Ahmed and 
Koob, 1997), sucrose pellets (Le et al, 1998; Mantsch and Goeders, 
1999), or sucrose solution (Buczek et al, 1999). However, more 
recently, Chen et al (2014b) showed that intermittent footshock 
modestly reinstates palatable food (high carbohydrate pellets) seeking 
in female rats with a history of ‘cafeteria diet' consumption during 
adolescence. There is also evidence that intermittent footshock stress 
reinstates operant responding previously reinforced by brain 
stimulation reward (Shalev et al, 2000); this finding is in agreement 
with results from an early study (Deutch and Howarth, 1962). In the 
studies described above, and in others reviewed below, the 
intermittent footshock stressor and other stressors (with the exception 
of 1 day food deprivation) were administered acutely just before the 
reinstatement test sessions. 
The reasons for the ‘selective' effect of intermittent footshock 
stress on reinstatement of drug vs food reward are unknown. As 
previously discussed, one possibility is that while certain physiological 
effects of intermittent footshock promote reward seeking, other effects 
of footshock induce physiological states that inhibit food intake and 
seeking (Shaham et al, 2000a). In this regard, one potential 
mechanism is hypothalamic corticotropin releasing factor (CRF), which 
is released after exposure to footshock and other stressors (Bale and 
Vale, 2004; Sawchenko et al, 2000), and causes inhibition of food 
intake (Glowa et al, 1992; Morley and Levine, 1982; Sekino et al, 
2004). As discussed below (section ‘Brain areas and circuits of stress-
induced reinstatement'), this classical effect of CRF on the 
hypothalamic-pituitary adrenal (HPA) axis (Dallman et al, 1995) 
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contrasts with CRF actions on extrahypothalamic systems, which 
promote stress-induced reinstatement of drug seeking (Erb et al, 
2001b). It is also possible that the ‘putative' selective effect of 
intermittent footshock on reinstatement of drug vs food seeking is due 
to the fact that the above negative studies with food were performed 
under experimental conditions in which footshock stress-induced 
reinstatement is often not observed with drugs like cocaine (eg, 
limited access daily sessions) (see section ‘Methodological 
considerations'). 
Generality to Other Behavioral Procedures 
In the studies described in section ‘Generality to other drug and 
non-drug rewards', footshock stress-induced reinstatement was 
determined using the operant version of the extinction-reinstatement 
model (Shaham et al, 2003). The effect of this stressor was also 
demonstrated in the conditioned place preference (CPP) variation of 
the model using cocaine (Wang et al, 2000). In the CPP reinstatement 
model, laboratory animals are trained to associate a distinct 
environment with drug injections, undergo extinction training during 
which they are exposed to the drug environment in the absence of 
drug, and then tested for reinstatement of drug CPP after stress 
exposure (Sanchez and Sorg, 2001; Wang et al, 2000). There is also 
evidence that intermittent footshock can re-establish morphine or 
cocaine CPP under experimental conditions in which the drug CPP is no 
longer observed after the passage of time without extinction training 
(Lu et al, 2000, 2001). Reinstatement of drug seeking after extinction 
has also been assessed in the runway operant model (Ettenberg, 
2009; Ettenberg et al, 1996). To date, however, we are not aware of 
published studies on the effect of intermittent footshock or other 
stressors on reinstatement of drug seeking in this model. 
Generality to Other Stressors 
Over the years, investigators have determined whether 
stressors other than intermittent footshock reinstate operant drug 
seeking or drug CPP. We discuss these results separately for the self-
administration and CPP variations of the reinstatement model. Table 1 
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provides a summary of the text in section ‘Generality to other 
stressors'. 
Table 1. Effects of Different Stressors on Reinstatement of Operant 
Drug Seeking and Conditioned Place Preference (CPP) 
  Self-administration 
 
CPP 
 
  Heroin Cocaine METH Nicotine Alcohol Morphine Cocaine 
Environmental stressors 
 Intermittent Footshock Yes Yes Yes Yes Yes Yes Yes 
 Food deprivation Yes Yes       No   
 Swim stress   Yes       Yes Yes 
 Cue paired with shock No No     Yes   Yes 
 Social defeat         No Yes Yes 
 Cue paired with social 
defeat 
        Yes     
 Restraint No         Yes Yes 
 Tail pinch           Yes   
 Quinine solution   Yes           
Pharmacological and neuropharmacological stressors 
 CRF Yes Yes           
 Yohimbine Yes Yes Yes Yes Yes   Yes 
 Kappa agonists   Yes         Yes 
 GABAA antagonists No No     No     
 Metyrapone Yes             
 Medial septum inactivation Yes             
Abbreviations: CRF, corticotropin-releasing factor; METH, methamphetamine. 
Stress-induced reinstatement of drug self-administration. Acute 
1-day food deprivation reinstates heroin and cocaine seeking (Shalev 
et al, 2000, 2003); these results are in agreement with an earlier 
finding that food restriction (about 30–40% of daily food ration) 
reinstates cocaine seeking in rats with a history of exposure to this 
stressor during the training phase (Carroll, 1985). Acute 1-day food 
deprivation also reliably reinstates cocaine seeking in mice (Highfield 
et al, 2002). Exposure to cues previously paired with social defeat 
stress, but not acute exposure to social defeat, modestly reinstates 
alcohol seeking (Funk et al, 2005). Conrad et al (2010) showed that 
acute exposure (4–5 min) to cold swim stress 24 h before the 
reinstatement tests reinstates cocaine seeking. Most recently, Twining 
et al (2015) showed that acute intraoral delivery of an aversive bitter 
quinine solution reinstates cocaine seeking. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropsychopharmacology, Vol 41, No. 1 (January 2016): pg. 335-356. DOI. This article is © © 2016 American College of 
Neuropsychopharmacology and permission has been granted for this version to appear in e-Publications@Marquette. 
American College of Neuropsychopharmacology does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from American College of 
Neuropsychopharmacology. 
8 
 
Pharmacological induction of a stress-like state by ventricular 
CRF injections reinstates heroin (Shaham et al, 1997), alcohol (Le et 
al, 2002), and cocaine (Erb et al, 2006) seeking. Similarly, systemic 
injections of the alpha-2 adrenoceptor antagonist yohimbine, which 
induces stress- and anxiety-like responses in humans and laboratory 
animals (Bremner et al, 1996a and b), reinstate methamphetamine 
(Shepard et al, 2004), alcohol (Le et al, 2005), cocaine (Feltenstein 
and See, 2006), and nicotine (Feltenstein et al, 2012) seeking in rats, 
and cocaine seeking in monkeys (Lee et al, 2004). However, the 
relevance of the potent effect of yohimbine on reinstatement of drug 
seeking to the general phenomenon of stress-induced reinstatement 
has been questioned in a recent study (Chen et al, 2014c) (see Box 2). 
Box 2. Yohimbine-Induced Reinstatement: does it Reflect 
Stress-Induced Reinstatement? 
Yohimbine is an alpha-2 adrenoceptor antagonist that has been 
used in numerous psychiatry-related studies as a pharmacological 
stressor in rodents, monkeys, and humans (Bremner et al, 1996a and 
b; Redmond and Huang, 1979). Over the last decade, yohimbine has 
become the most common stress manipulation in studies on 
reinstatement of drug and food seeking (Bossert et al, 2013; Calu et 
al, 2014; Nair et al, 2009) for three main reasons. The first is that the 
effect of yohimbine on reinstatement is less variable and more robust 
than the effect of intermittent footshock (Le et al, 2005; Shepard et al, 
2004). The second is that early studies showed that like intermittent 
footshock the effect of yohimbine on reinstatement of food and alcohol 
is blocked by CRF1 receptor antagonists, which likely act at 
extrahypothalamic brain areas (Ghitza et al, 2006; Marinelli et al, 
2007). The third reason was the intuitive appeal of using the same 
stressor in the animal model and in humans (Greenwald et al, 2013; 
See and Waters, 2010). 
However, with the increasing use of yohimbine in reinstatement 
studies, evidence emerges for behavioral and pharmacological 
differences between the effects of intermittent footshock and 
yohimbine on reward seeking. Unlike footshock, yohimbine reinstates 
food seeking and also increases alcohol and food self-administration 
(Cifani et al, 2012; Le et al, 2005). Unlike intermittent footshock, 
yohimbine does not induce stress-related 22 kHz ultrasonic distress 
vocalizations (Mahler et al, 2013). Unlike intermittent footshock, the 
effect of yohimbine on reinstatement of cocaine seeking or cocaine CPP 
is not blocked by the alpha-2 adrenoceptor agonist clonidine (Brown et 
al, 2009; Mantsch et al, 2010). These differences between yohimbine 
and intermittent footshock raise the possibility that the effect of 
yohimbine on reinstatement of reward seeking might not be due to its 
ability to induce a stress-like state that motivates drug or food 
seeking. 
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This issue was addressed in a recent study by Chen et al 
(2014c) in which they determined whether yohimbine's effect on 
operant responding is dependent on previous reward history or cue 
contingency, and whether yohimbine (at a dose used in reinstatement 
studies) induces an aversive stress-like state, as assessed by the 
CPP/CPA (conditioned place aversion) method. Chen et al reported that 
the magnitude of yohimbine-induced operant responding during the 
reinstatement tests was critically dependent on the contingency 
between lever pressing and discrete tone-light cue delivery, but not 
the previous history with food reward during training. Specifically, 
yohimbine potently and dose-dependently increased operant lever-
pressing that was not previously reinforced with either food or drug. 
They also showed that repeated pairing of yohimbine (2 mg/kg) with a 
distinct context causes modest CPP to this context. The highly 
unexpected conclusion from this study was that yohimbine's effects on 
operant responding in reinstatement studies are likely independent of 
the history of contingent self-administration of food or drug rewards 
and may not be related to the commonly assumed stress-like effects of 
yohimbine. Chen et al (2014c) proposed that the primary action of 
yohimbine in reinstatement studies is to invigorate responding for 
cues, which before pairing with drug or non-drug rewards or after 
extinction, have weak motivational effects in rodents. 
Another class of putative pharmacological stressors is kappa 
opioid receptor (KOR) agonists, which induce stress-like states in 
humans and laboratory animals (Bruchas et al, 2010; Van't Veer and 
Carlezon, 2013). In rats, systemic injections of the KOR agonist 
U50,488 reinstate nicotine and alcohol seeking (Funk et al, 2014; 
Grella et al, 2014). In monkeys, systemic injections of KOR agonists 
(spiradoline and enadoline) reinstate cocaine seeking (Valdez et al, 
2007). Another potential demonstration of the effect of 
pharmacological stressors on reinstatement is the finding that 
metyrapone potently reinstates heroin seeking (Shaham et al, 1997). 
Metyrapone is a corticosterone synthesis inhibitor (Jenkins et al, 1958) 
that has been used in numerous endocrinology studies (Haynes, 
1990). However, the drug also activates extrahypothalamic brain 
areas, including the central amygdala (CeA) nucleus (Rotllant et al, 
2002), which has an important role in stress-induced reinstatement 
(section ‘Brain areas and circuits of stress-induced reinstatement'). 
Finally, another class of pharmacological stressors, GABAa antagonists 
or inverse receptor agonists like pentylenetetrazole or FG7142, had no 
effect on reinstatement of cocaine (Waters and See, 2011), heroin, or 
alcohol (Y Shaham, AD Le, unpublished observations) seeking. 
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One study showed that a cue previously paired with footshock 
(a conditioned fear manipulation) reinstates alcohol seeking (Liu and 
Weiss, 2003). However, earlier studies reported that conditioned fear 
exposure has no effect on reinstatement of heroin or cocaine seeking 
(Shaham et al, 2000a). A possible reason for the negative results is 
that the predominant effect of cues paired with shock is freezing 
(LeDoux, 2000), a behavior that is incompatible with lever-pressing 
behavior. Exposure to restraint stress in a novel context had no effect 
on reinstatement of heroin seeking (Shalev et al, 2000). As 
intermittent footshock stress is effective when given in the drug self-
administration context, but has no effect on reinstatement of heroin 
seeking when given in a novel context, a potential account for the 
negative results with restraint stress is that the phenomenon of stress-
induced reinstatement is context-specific (Shalev et al, 2000). Finally, 
the effect of footshock on reinstatement of heroin seeking is mimicked 
by reversible inactivation of the medial septum (Highfield et al, 2000). 
Previous studies have shown that septal lesions cause stress-like 
physiological and psychological responses (Gray, 1987; Holdstock, 
1967). 
Stress-induced reinstatement of CPP. Exposure to several stressors 
induces reinstatement of drug CPP after extinction in rats and mice. 
Swim stress reinstates cocaine CPP in mice (Carey et al, 2007; 
Kreibich and Blendy, 2004; Redila and Chavkin, 2008) and morphine 
CPP in rats (Li et al, 2013; Ma et al, 2007). Restraint stress reinstates 
cocaine CPP in rats (Sanchez et al, 2003) and morphine CPP in mice 
(Ribeiro Do Couto et al, 2006). Tail pinch and social defeat reinstate 
morphine CPP in mice (Ribeiro Do Couto et al, 2006). A conditioned 
fear manipulation reinstates cocaine CPP in rats (Sanchez and Sorg, 
2001). Additionally, as in the operant reinstatement model, systemic 
injections of the putative pharmacological stressors U50,488 (a KOR 
agonist) (Redila and Chavkin, 2008) and yohimbine (Mantsch et al, 
2010) reinstate cocaine CPP in mice. However, 1-day food deprivation, 
which reinstates operant heroin seeking in rats (Shalev et al, 2000), 
has no effect on reinstatement of morphine CPP (Ma et al, 2007). 
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Methodological Considerations 
In the sections above, we summarize results from studies in 
which stressors reinstate drug seeking and CPP. However, particularly 
in the case of the intermittent footshock stressor, whether or not the 
stressor reinstates operant drug seeking is dependent on several 
critical methodological factors. One factor is the context of footshock 
exposure: under identical experimental conditions, intermittent 
footshock reinstates heroin seeking when it is administered in the drug 
self-administration context but not in a novel context (Shalev et al, 
2000). These findings are in agreement with results from conditioned 
fear studies where a footshock previously paired with a conditioned 
stimulus (CS) reinstates the response to the CS after extinction only 
when rats are exposed to the stressor in the training context, but not 
in a novel context (Bouton and King, 1983; Bouton and 
Swartzentruber, 1991). 
A second factor is the duration of the withdrawal period. Shalev 
et al (2001) used a variation of the reinstatement model in which 
extinction of operant responding and subsequent footshock-induced 
reinstatement is determined in the same daily session (Shalev et al, 
2002) to demonstrate the time-dependent changes in this 
reinstatement after withdrawal from heroin. The stressor reinstated 
heroin seeking after 6, 12, 25, and 66 withdrawal days but not after 1 
day. In this study, the magnitude of stress-induced reinstatement was 
maximal after 6 or 12 days. 
A third factor is the amount of drug intake during drug self-
administration training. For both heroin (Ahmed et al, 2000) and 
cocaine (Mantsch et al, 2008), intermittent footshock-induced 
reinstatement of drug seeking is higher in magnitude and more 
robust/reliable in rats with a history of extended daily drug access (6–
11 h/day) than in rats with a history of limited daily drug access (1–
2 h/day). 
A fourth factor is the availability of discrete infusion cues during 
all phases of the experiment (training, extinction, and reinstatement). 
Shelton and Beardsley (2005) showed that under identical 
experimental conditions, intermittent footshock reinstates cocaine 
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seeking in the presence but not in the absence of a discrete infusion 
cue previously paired with cocaine infusions during training. This 
finding is in agreement with the notion that a potential mechanism for 
footshock-induced reinstatement is that the stressor reinstates the 
incentive motivational effects of drug cues (Shaham and Stewart, 
1995). Additional support for this notion is that intermittent footshock 
potentiates cue-induced reinstatement of cocaine and alcohol seeking 
(Buffalari and See, 2009; Liu and Weiss, 2002a). In the cue-induced 
reinstatement procedure, an operant response reinforced by a discrete 
drug cue is determined after drug self-administration training in the 
presence of the cue and extinction training in its absence (Meil and 
See, 1996). 
A fifth factor is baseline stress levels before footshock exposure 
during the reinstatement tests. In general, while this variable has not 
been experimentally manipulated like the other factors described 
above, anecdotal evidence suggests that footshock-induced 
reinstatement is not readily observed when the baseline stress level is 
high, because under these conditions the predominant effect of the 
stressor during the reinstatement test is prolonged freezing. This idea 
has led to the development of a modified stress-induced reinstatement 
procedure in which rats are first given several days of extinction 
training, and during the subsequent reinstatement test they are given 
several hours of extinction training before footshock exposure (Erb et 
al, 1996; Kupferschmidt et al, 2011). Presumably, intermittent 
footshock reliably reinstates drug seeking in this procedure because 
the rat's basal stress level is relatively low several hours after being 
exposed to non-specific stressors (eg, handling and transferred from 
the animal facility to the test chambers). 
Summary 
The phenomenon of intermittent footshock stress-induced 
reinstatement of drug seeking, originally reported with heroin-trained 
rats, generalizes to other drugs of abuse and is also observed in the 
CPP variation of the reinstatement model. This phenomenon also 
generalizes to certain environmental and pharmacological stressors 
but not others. Additionally, it appears that the number of stressors 
that are effective in the CPP variation of the reinstatement model is 
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more diverse than in the operant variation of the model (Table 1). 
Furthermore, several methodological factors are critical for a reliable 
effect of intermittent footshock stress on reinstatement of drug 
seeking. These factors include the context of footshock exposure, high 
drug intake during training, the withdrawal period duration, the 
presence of the extinguished discrete drug cues during testing, and 
basal (baseline) stress levels before footshock exposure in the 
reinstatement tests. 
Finally, in all the published studies on stress-induced 
reinstatement, the reinstating stressors have been both uncontrollable 
and unpredictable. Thus, a question for future research is whether 
these features of stressors are critical for their effect on reinstatement 
of drug seeking. Based on previous studies investigating the inhibitory 
effect of both stress controllability and predictability on physiological 
and psychological stress responses in laboratory animals (Maier, 1984; 
Seligman and Maier, 1967) and humans (Cohen et al, 1986; Glass and 
Singer, 1972), we predict that controllable or predictable stressors will 
have a weak effect on reinstatement of drug seeking. Additionally, in 
the studies reviewed above, the stressors were administered acutely 
before the reinstatement test session. Thus, another question for 
future research is whether prior exposure to stress, which often leads 
to subsequent sensitization of stress responses (Antelman et al, 2000; 
Kvetnansky et al, 2009) and cross sensitization of the behavioral and 
neurochemical responses to drugs (Kalivas and Stewart, 1991), would 
potentiate the stressors' effect on reinstatement of drug seeking. 
Brain Areas and Circuits of Stress-Induced 
Reinstatement 
Since 1995 many studies have determined the effects of 
systemic and intracranial injections of pharmacological agents 
targeting different receptor classes on stress-induced reinstatement of 
drug seeking or CPP. Due to space limitations, we summarize most of 
the systemic pharmacology data in Tables 2 and and33 but do not 
discuss them in detail in our review. The brain circuitry data that we 
discuss below are primarily based on the use of intermittent footshock 
in the self-administration- and CPP-based reinstatement models with 
different drug classes in rats, and the use of swim stress in the CPP-
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based procedure with cocaine in mice. During the last several years, 
many investigators have also determined the neuropharmacological 
mechanisms underlying yohimbine-induced reinstatement of drug 
seeking and CPP (Bossert et al, 2013; Mantsch et al, 2014; See and 
Waters, 2010). However, as discussed in Box 2, yohimbine's effects on 
operant responding during reinstatement testing are likely 
independent of the history of contingent drug self-administration and 
may not be related to the commonly assumed stress-like effects of 
yohimbine. Therefore, we only mention results from yohimbine-related 
studies when a given neuropharmacological manipulation affected both 
intermittent footshock- and yohimbine-induced reinstatement. 
Table 2. Effect of Systemic Injections of Different Pharmacological 
Agents on Stress-Induced Reinstatement of Operant Drug and Food 
Seeking 
Neurotransmitter/hormonal 
systems and drugs 
Species Training 
history 
Stressor Effect References 
CRF 
 CRF1 receptor antagonists: 
CP154,526, antalarmin, MTIP 
Rat, 
mouse 
A, C, F, 
H, N 
FS, Y ↓ Gehlert et al (2007), 
Ghitza et al (2006), 
Hansson et al (2006), Le 
et al (2000), Marinelli et 
al (2007), Plaza-Zabala 
et al (2010), and 
Shaham et al (1998) 
Steroid hormones 
 Allopregnanolone Rat C Y ↓, ↔ Anker and Carroll 
(2010b) and Regier et al 
(2014) 
 Corticosterone synthesis 
inhibitor: ketoconazole 
Rat C FS ↓ Mantsch and Goeders 
(1999) 
 Glucocorticoid antagonist: RU486 Rat A Y ↓ Simms et al (2012) 
Noradrenaline 
 Alpha-1 antagonist: prazosin Rat A, F FS, Y ↓ Le et al (2011) 
 Alpha-2 agonists: clonidine, 
lofexidine, guanfacine 
Rat A, C, H, 
N 
FS, Y ↓ Brown et al (2009), 
Buffalari et al (2012), 
Erb et al (2000), Le et al 
(2011, 2005), Shaham 
et al (2000b), Zislis et al 
(2007) 
 NA synthesis inhibitor: 
Nepicastat 
Rat C FS, Y ↓ Schroeder et al (2013) 
Dopamine 
 D1-family antagonists: 
SCH23390, SCH 39166 
Rat C, H FD, FS, Y ↓, ↔ Brown et al (2012), 
Shaham and Stewart 
(1996), and Tobin et al 
(2009, 2013) 
 D2-family antagonist: raclopride Rat C, H FD, FS, Y ↔ Brown et al (2012), 
Shaham and Stewart 
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Neurotransmitter/hormonal 
systems and drugs 
Species Training 
history 
Stressor Effect References 
(1996), Tobin et al 
(2009) 
 Mixed D1/D2 antagonists: 
tetrahydropalmatine, flupenthixol 
Rat C, H FS ↓ Figueroa-Guzman et al 
(2010) and Shaham and 
Stewart (1996) 
 D3-family antagonist: SB-
277011A 
Rat C FS ↓ Xi et al (2004) 
Serotonin 
 Reuptake blockers/releasers: 
fluoxetine, dexfenfluramine 
Rat A FS ↓ Le et al (2006, 1999) 
 5-HT 1A antagonist: WAY 
100,635 
Rat A Y ↓ Le et al (2009) 
 5-HT 2C agonist: Ro60-0175 Rat A, C Y ↓ Fletcher et al (2008) 
 5-HT3 antagonists: ondansetron, 
tropisetron 
Rat A FS ↓ Le et al (2006) 
Cannabinoids 
 FAAH inhibitor: URB597 Rat A FS, Y ↔ Cippitelli et al (2008) 
 CB1 antagonist: SR-141716A Rat A FS ↔ Economidou et al (2007) 
Dynorphin 
 Kappa antagonists: JDTic, Nor-
BNI, RTI-194 
Rat A, C, H, 
N 
FD, FS, 
FSS, Y 
↓, ↔ Beardsley et al (2005, 
2010), Funk et al 
(2014), Grella et al 
(2014), Polter et al 
(2014), Schank et al 
(2012) and Sedki et al 
(2015) 
Enkephalin/endorphin 
 δ receptor antagonist: SoRI9409 Rat A Y ↓ Nielsen et al (2012) 
GABA 
 GABA agonist: pregabalin Rat A, C Y ↓ de Guglielmo et al 
(2013) and Stopponi et 
al (2012) 
Glutamate 
 m-GLUR2/3 agonist: LY379268 Rat A, C FS ↓ Martin-Fardon and Weiss 
(2012), Sidhpura et al 
(2010), Zhao et al 
(2006) 
 m-GLU5 antagonist: MTEP Rat C FS ↓ Martin-Fardon and Weiss 
(2012) and Sidhpura et 
al (2010) 
Hypocretins 
 Hypocretin-1 receptor 
antagonist: SB334867 
Rat, 
mouse 
A, C, F FS, Y ↓, ↔ Boutrel et al (2005), Nair 
et al (2008), Plaza-
Zabala et al (2010), 
Richards et al (2008 and 
Zhou et al (2012) 
Neuropeptides 
 Neuropeptide Y R2 and R5 
antagonists: JNJ-31020028, Lu 
AA33810 
Rat A, H FD, FS ↓, ↔ Cippitelli et al (2011) 
and Maric et al (2011) 
 Neurokinin 1 receptor 
antagonist: L822429 
Rat A, C FS, Y ↓ Schank et al (2014, 
2011) 
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Neurotransmitter/hormonal 
systems and drugs 
Species Training 
history 
Stressor Effect References 
 Neuropeptide S antagonist: RTI-
118 
Rat C Y ↓ Schmoutz et al (2012) 
 Nociceptin/orphanin receptor 
agonist: MT-7716 
Rat A FS, Y ↓ Ciccocioppo et al (2014) 
and de Guglielmo et al 
(2014) 
Others 
 PPARγ agonist: Pioglitazone Rat A Y ↓ Stopponi et al (2013, 
2011) 
 Alpha-3/beta-4 nACh partial 
agonist: AT-1001 
Rat A Y ↓ Cippitelli et al (2015) 
Abbreviations for training history: A, alcohol; C, cocaine, F, food; H, heroin; M, 
methamphetamine; N, nicotine. Abbreviations for stressors: FD, food deprivation (1 
d); FS, intermittent footshock; FSS, forced swim stress; Y, yohimbine. Abbreviations 
for symbols: ↓, decrease; ↔, no effect. 
 
Table 3. Effect of Systemic Injections of Different 
Pharmacological Agents on Stress-Induced Reinstatement of 
Conditioned Place Preference 
Neurotransmitter/hormonal 
systems and drugs 
Species Training 
history 
Stressor Effect References 
CRF 
 CRF1 receptor antagonist: 
CP154,526 
Rat C, M FS ↓ Lu et al (2001) 
Noradrenaline 
 Alpha-1 antagonist: Prazosin Mouse C FSS, Y ↔ Mantsch et al (2010) 
 Alpha-2 agonist: Clonidine Mouse C FSS, Y ↓, ↔ Mantsch et al (2010) 
 Beta-1 antagonist: betaxolol Mouse C FSS ↓ Vranjkovic et al (2012) 
 Beta-2 antagonists: 
Propranolol, ICI-118,551 
Mouse C FSS, Y ↓ Mantsch et al (2010) 
and Vranjkovic et al 
(2012) 
Cannabinoids 
 Cannabinoid antagonist: AM-
251 
Rat C FSS ↓ Vaughn et al (2012) 
Dynorphin 
 Kappa antagonists: Nor-BNI, 
CJ-15,208, PF-04455242, 
Zyklophin 
Mouse C, N FSS ↓ Aldrich et al (2009, 
2013), Eans et al 
(2013), Grimwood et al 
(2011), Jackson et al 
(2013), McLaughlin et 
al (2003) and Redila 
and Chavkin (2008) 
Other transmitters 
 Cholecystokinin receptor A and 
B antagonists: Devazepide, 
L365,260 
Rat C FS ↓, ↔ Lu et al (2002) 
 NMDA 2B receptor antagonist: 
ifenprodil 
rat M FSS ↔ Ma et al (2007) 
Abbreviations for training history: A, alcohol; C, cocaine, M, morphine; N, nicotine. 
Abbreviations for stressors: FS, intermittent footshock; FSS, forced swim stress; Y, 
yohimbine. Abbreviations for symbols: ↓, decrease; ↔, no effect. 
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Bed Nucleus of Stria Terminalis and CeA 
The bed nucleus of stria terminalis (BNST) and the CeA are 
known to have important roles in stress responses (Davis et al, 2010; 
LeDoux, 2000) that involve activation of noradrenaline and CRF 
systems (Davis et al, 1997; Flavin and Winder, 2013; McGaugh, 2004; 
Silberman and Winder, 2013). Studies using systemic or ventricular 
drug injections have shown that CRF receptor antagonists and alpha-2 
adrenoceptor agonists like clonidine (which inhibit noradrenaline cell 
firing and release) decrease stress-induced reinstatement of drug 
seeking and drug CPP (Mantsch et al, 2014; Shaham et al, 2000a; 
Shalev et al, 2010) (Tables 2 and and3).3). Conversely, ventricular 
injections of CRF or noradrenaline mimic the effect of intermittent 
footshock stress on reinstatement (Brown et al, 2009; Erb et al, 2006; 
Le et al, 2000; Shaham et al, 1997). Studies using endocrinology 
methods (adrenalectomy, corticosterone replacement) have also 
shown that CRF's role in footshock-induced reinstatement does not 
involve stress-induced activation of the HPA axis, indicating a role of 
extrahypothalamic CRF systems (Erb et al, 2001a; Lu et al, 2003). 
Based on these results, investigators have studied the involvement of 
CRF and noradrenaline in BNST and CeA in stress-induced 
reinstatement and CPP. We describe these studies below. (Note: in 
Box 3 we discuss in more detail the role of corticosterone and the HPA 
axis in stress-induced reinstatement.) 
Box 3. Corticosterone, the HPA Axis, and Stress-Induced 
Reinstatement 
As mentioned in the main text, studies using endocrinology 
methods of adrenalectomy and adrenalectomy plus corticosterone 
replacement showed that stress-induced activation of the HPA axis and 
subsequent release of corticosterone does not have a role in stress-
induced reinstatement of drug seeking (Erb et al, 1998; Le et al, 2000; 
Shaham et al, 1997; Shalev et al, 2006, 2003; Graf et al, 2011). 
However, at least in the case of cocaine, basal corticosterone levels 
are critical for stress-induced reinstatement (Erb et al, 1998; Shalev et 
al, 2003), suggesting a permissive role of the stress hormone in this 
reinstatement. Additionally, exogenous administration of 
corticosterone reinstates cocaine seeking (Deroche et al, 1997). 
More recently, there is evidence for a role of corticosterone in 
two emerging important phenomena related to stress-induced 
reinstatement. The first is that as mentioned in section ‘Generality of 
stress-induced reinstatement', footshock stress-induced reinstatement 
is significantly stronger and more robust in rats with a history of 
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extended (6 h/day) vs limited (1–2 h/day) access to cocaine (Mantsch 
et al, 2014). Under these conditions, adrenalectomy before self-
administration training prevents stress-induced reinstatement while 
the same manipulation after training is ineffective (Graf et al, 2011), 
suggesting that cocaine-induced corticosterone-dependent 
neuroadaptations are critical for footshock-induced reinstatement. 
Second, there is evidence that footshock, under conditions in 
which it has no effect on reinstatement on its own, strongly 
potentiates the ability of both cocaine priming and cocaine cues to 
reinstate drug seeking (Buffalari and See, 2009; Graf et al, 2013). The 
mechanism/s underlying the ‘indirect' potentiation effect of stress is 
largely unknown but it appears that corticosterone has a critical role. 
Graf et al (2013) showed that this effect of mild stress is reversed by 
adrenalectomy but not by systemic injections of the glucocorticoid 
receptor antagonist RU486. Next, these authors showed that the 
potentiating effect of mild stress on cocaine priming is mediated by a 
novel mechanism of action in NAc that involves glucocorticoid-
dependent blockade of dopamine clearance by the monoamine 
transporter, organic cation transporter 3 (OCT3). 
The CRF projections from CeA to BNST, Erb and Stewart (1999) 
showed that injections of the CRF receptor antagonist D-Phe CRF12–41 
into the BNST (ventral region) but not CeA decrease footshock-induced 
reinstatement of cocaine seeking. They also showed that CRF 
injections into the BNST but not CeA reinstate cocaine seeking; this 
finding was confirmed by Vranjkovic et al (2014). In agreement with 
these findings, Wang et al (2006) showed that BNST but not CeA 
injections of the selective CRF1 receptor antagonist CP-154,526 
(Schulz et al, 1996) decrease footshock-induced reinstatement of 
morphine CPP. However, while blockade or activation of CeA CRF 
receptors had no effect on footshock-induced reinstatement, Erb et al 
(2001a) reported data suggesting that a CRF projection from CeA to 
BNST (Sakanaka et al, 1986) has a role in this reinstatement. They 
used an asymmetric anatomical disconnection method (Gold, 1966) 
and showed that injections of tetrototoxin (TTX, a sodium channel 
blocker that inhibits neuronal activity) into the CeA in one hemisphere 
and D-Phe CRF12–41 into the BNST in the contralateral hemisphere 
decrease footshock-induced reinstatement of cocaine seeking. 
Taken together, these results suggest that stress-induced 
activation of CRF projections from CeA to BNST and subsequent 
activation of CRF receptors (presumably the CRF1 subtype) in the 
BNST are critical for stress-induced reinstatement of drug seeking and 
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CPP. However, the circuitry (projection) data are based on the use of 
TTX, which also inhibits fiber of passage and non-CRF neurons that 
project to BNST (Cassell et al, 1999). Therefore, it is likely that within 
the BNST, CRF-related mechanisms that are independent of the CeA to 
BNST CRF projection also have a role in stress-induced reinstatement. 
Noradrenaline in CeA and BNST and interaction between 
noradrenaline and CRF in BNST. Leri et al (2002) showed that 
injections of a mixture of beta-1 and beta-2 adrenoceptor antagonists 
(betaxolol+ICI-118,551) into both the BNST (the injections were in 
both dorsal and ventral BNST) and the CeA decrease footshock-
induced reinstatement of cocaine seeking. Subsequently, Vranjkovic et 
al (2014) showed that within the ventral BNST, this effect is mediated 
by the beta-2 adrenoceptor: local ICI-118,551 but not betaxolol 
injections decrease stress-induced reinstatement. Additionally, they 
showed that ventral BNST injections of the beta-2 adrenoceptor 
agonist clenbuterol, but not the beta-1 adrenoceptor agonist 
dobutamine, mimic the effect of footshock on reinstatement. Additional 
evidence for a role of BNST and CeA noradrenaline in stress-induced 
reinstatement is that BNST and CeA injections of clonidine decrease 
footshock-induced reinstatement of morphine CPP (Wang et al, 2001) 
and footshock-induced reinstatement of nicotine seeking (Yamada and 
Bruijnzeel, 2011). These data, however, are difficult to interpret in the 
absence of additional anatomical and pharmacological controls, 
because clonidine is highly lipophilic and it can readily diffuse to the 
nearby areas, or in the case of the BNST, to the ventricles. Finally, 
based on the earlier results of Leri et al (2002), an unexpected finding 
of Yamada and Bruijnzeel (2011) is that CeA injections of the non-
selective beta adrenoceptor antagonist propranolol have no effect on 
footshock-induced reinstatement of nicotine seeking. 
Ascending noradrenaline systems originate from two clusters of 
neurons, the locus coeruleus (LC, A6) and the lateral tegmental nuclei 
(A1, A2 (located in nucleus tractus solitarii, NTS), A4); these neurons 
project to many brain areas via the dorsal and ventral noradrenergic 
bundles, respectively (Kvetnansky et al, 2009; Moore and Bloom, 
1979). The lateral tegmental nuclei, which provide the main source of 
noradrenaline to BNST and CeA (Aston-Jones et al, 1999; Fritschy and 
Grzanna, 1991), but not the LC, are critical for stress-induced 
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reinstatement of drug seeking and CPP. 6-OHDA lesions of the ventral 
noradrenergic bundle decrease footshock-induced reinstatement of 
heroin seeking (Shaham et al, 2000b) and morphine CPP (Wang et al, 
2001). In contrast, injections of clonidine or its charged analog ST-91 
into the LC have no effect on this reinstatement (Shaham et al, 2000b; 
Wang et al, 2001). 
Finally, there is evidence that an interaction between CRF and 
noradrenaline in the BNST is critical for footshock-induced 
reinstatement of cocaine seeking. In an initial study, Brown et al 
(2009) showed that reinstatement of cocaine seeking induced by 
ventricular injections of noradrenaline is decreased by pretreatment 
with the CRF receptor antagonist D-Phe CRF12–41. In contrast, 
reinstatement induced by ventricular injections of CRF is not blocked 
by the alpha-2 adrenoceptor agonist clonidine. These data suggest 
that the role of CRF in stress-induced reinstatement is downstream 
from stress-induced activation of noradrenaline systems. The likely 
brain site for this noradrenaline-CRF interaction is the BNST. 
Vranjkovic et al (2014) showed that reinstatement of cocaine seeking 
induced by ventral BNST injections of the beta-2 adrenoceptor agonist 
clenbuterol is blocked by local injections of the CRF1 receptor 
antagonist antalarmin (Bornstein et al, 1998). 
Taken together, stress-induced activation of lateral tegmental 
noradrenergic nuclei and subsequent actions of noradrenaline in both 
the BNST and CeA are critical for stress-induced reinstatement of drug 
seeking and CPP. Additionally, within the ventral BNST, stress-induced 
activation of CRF and subsequent stress-induced reinstatement are 
downstream from stress-induced activation of lateral tegmental 
noradrenergic nuclei that project to this brain area. 
Other evidence for a role of BNST and CeA in stress-induced 
reinstatement. Several other lines of evidence also indicate critical 
roles for the BNST and CeA in stress-induced reinstatement of drug 
seeking and CPP. Reversible inactivation of ventral BNST or CeA with 
GABAa and GABAb receptor agonists (muscimol+baclofen) decreases 
footshock-induced reinstatement of cocaine seeking (McFarland et al, 
2004). Additionally, TTX injections into either the BNST or CeA 
decrease footshock-induced reinstatement of heroin seeking (Shaham 
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et al, 2000a) and this reinstatement is associated with increased CRF 
mRNA in both brain areas (Shalev et al, 2001). However, both sets of 
data should be interpreted with caution. As mentioned above, a 
methodological issue with TTX inactivation data is that the drug 
inactivates both cell bodies and fibers of passage. Additionally, the 
relevance of the CRF mRNA expression data to CRF's role in stress-
induced reinstatement is unclear, because within the BNST footshock 
selectively increases expression in dorsal but not in ventral BNST, 
while the pharmacological data described above are primarily based on 
ventral BNST injections. 
Other relevant evidence is that systemic injections of the beta-2 
adrenoceptor antagonist ICI-118,551 decrease swim stress-induced 
reinstatement of cocaine CPP and prevent increases in CRF mRNA in 
BNST (but not CeA) in mice (McReynolds et al, 2014). However, under 
somewhat different experimental conditions, exposure to swim stress 
increases CRF mRNA in CeA in cocaine-experienced mice (Cleck et al, 
2008). In agreement with the latter findings, Nawata et al (2012) 
showed that a CRF receptor antagonist (alpha-helical-CRF9-41) 
decreases footshock-induced reinstatement of methamphetamine 
seeking in rats; additionally, using enzyme-linked immunosorbent 
assay (ELISA) they showed that CRF protein levels in CeA are 
increased after 10 but not 5 days of withdrawal from 
methamphetamine. The relevance of the ELISA data to the 
pharmacological data with the CRF receptor antagonist is unknown. 
Finally, studies using markers of neuronal activity such as Fos 
and pCREB (a downstream target of Fos activation) showed that swim 
stress-induced reinstatement of cocaine CPP in mice is associated with 
increased CREB activity (phosphorylation) in amygdala but not in BNST 
(Kreibich and Blendy, 2004). In a subsequent study, however, Briand 
et al (2010) showed that swim stress increases Fos expression in both 
ventral and dorsal BNST and that reversible inactivation of the BNST 
with lidocaine decreases swim stress-induced reinstatement of cocaine 
CPP. Additionally, Buffalari and See (2011) showed that reversible 
inactivation with muscimol+baclofen of the BNST decreases 
yohimbine-induced reinstatement of cocaine seeking and yohimbine-
induced potentiation of cue-induced cocaine seeking. 
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Summary. The studies reviewed above indicate that the BNST 
(primarily the ventral BNST) and CeA have important roles in stress-
induced reinstatement of drug seeking across drug classes and are 
also involved in stress-induced reinstatement of morphine and cocaine 
CPP. These roles include stress-induced activation of the lateral 
tegmental nuclei that provide the main noradrenergic innervation to 
BNST and CeA, and potentially the CRF projection from CeA to BNST. 
Within the BNST, stress-induced CRF activation and subsequent stress-
induced reinstatement are likely downstream from stress-induced 
activation of lateral tegmental noradrenaline neurons. 
Ventral Tegmental Area, Media Prefrontal Cortex, 
Orbital Frontal Cortex, and Nucleus Accumbens 
Neuronal activity in the mesocorticolimbic dopamine system, 
which comprises cell bodies in ventral tegmental area (VTA) that 
project to medial prefrontal cortex (mPFC), orbital frontal cortex 
(OFC), nucleus accumbens (NAc), amygdala, BNST, and other brain 
areas, has an important role in reinstatement of drug seeking induced 
by discrete cues (See, 2005), discriminative cues (Weiss, 2005), 
contextual cues (Marchant et al, 2014), and drug priming (Kalivas and 
McFarland, 2003; Pierce and Kumaresan, 2006; Self, 2004). Early 
studies have shown that different stressors strongly and preferentially 
activate the dopaminergic projection from VTA to mPFC (the 
mesocortical dopamine system) (Bannon and Roth, 1983; Deutch and 
Roth, 1990; Thierry et al, 1976). Subsequent studies, however, 
showed that stressors can also activate the dopaminergic projection 
from VTA to NAc (a component of the mesolimbic dopamine system) 
(Cabib and Imperato, 1996; Kalivas and Stewart, 1991). 
Based on these findings, the first two studies on intermittent 
footshock-induced reinstatement of drug seeking explored the role of 
mesolimbic dopamine. In the first study, Shaham and Stewart (1995) 
showed that footshock-induced reinstatement of heroin seeking is 
associated with increased dopamine release in NAc. In the second 
study, they showed that systemic injections of the mixed dopamine 
receptor antagonist flupenthixol decrease this reinstatement (Shaham 
and Stewart, 1996). In a subsequent anatomical mapping study, 
McFarland et al (2004) showed that reversible inactivation with 
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muscimol+baclofen of VTA, dorsal mPFC, NAc core and shell, and 
ventral pallidum (a downstream output of NAc via the ‘indirect' 
pathway) decreases footshock-induced reinstatement of cocaine 
seeking. Below, we describe subsequent mechanistic studies on the 
role of different brain areas of the mesocorticolimbic system in stress-
induced reinstatement of drug seeking and CPP. 
Glutamate, CRF, and Kappa/dynorphin in VTA. Glutamate input to 
VTA arrives from several brain regions (Geisler et al, 2007; 
Omelchenko and Sesack, 2007) and controls the activity of VTA 
dopamine neurons under basal conditions (Westerink et al, 1996; 
White et al, 1995) and after stress exposure (Enrico et al, 1998; 
Takahata and Moghaddam, 1998). Based on these studies, Wise and 
colleagues studied the role of VTA glutamate in stress-induced 
reinstatement of cocaine and heroin seeking. They showed that 
footshock-induced reinstatement of both heroin and cocaine seeking is 
associated with increased VTA glutamate release and that this 
reinstatement is decreased by local blockade of ionotropic glutamate 
receptors with kynurenic acid (Wang et al, 2005, 2012). 
VTA dopamine and glutamate transmission is also controlled by 
local CRF signaling (Kalivas et al, 1987; Ungless et al, 2003) from 
unspecified sources and, as discussed above, CRF has a critical role in 
stress-induced reinstatement of drug seeking and CPP. Based on these 
findings, Wise and colleagues studied the role of VTA CRF in stress-
induced reinstatement of cocaine seeking. In the first study, they 
showed that VTA perfusion (via a microdialysis probe) of alpha-helical 
CRF9–41 decreases footshock-induced reinstatement and that local CRF 
perfusion reinstates cocaine seeking (Wang et al, 2005); see also 
Wang et al (2009) for a replication of the VTA CRF effect on 
reinstatement. Next, they showed that footshock-induced 
reinstatement of cocaine seeking is decreased by VTA perfusion of a 
selective CRF2 receptor antagonist or an inhibitor of the CRF binding 
protein but not by a selective CRF1 receptor antagonist. Moreover, 
they showed that VTA perfusion of CRF or CRF2 receptor agonists with 
strong affinity for CRF-BP (binding protein) causes reinstatement of 
cocaine seeking, whereas CRF receptor agonists that do not bind CRF-
BP are ineffective (Wang et al, 2007). 
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These are surprising findings from two perspectives. The first is 
that previous studies discussed above (see also Tables 2 and and3)3) 
implicate CRF1 but not CRF2 receptors in stress-induced 
reinstatement. The second is that anatomical studies indicate that 
CRF1 receptors are the predominant postsynaptic CRF receptors in VTA 
and that CRF2 receptor expression is not detected by traditional in situ 
hybridization methods (Van Pett et al, 2000). Another issue to 
consider in studies using putative selective CRF2 antagonists is that 
their CRF2/CRF1 ratio selectivity is moderate, and some commonly 
used CRF2 antagonists like antisauvagine-30 have behavioral effects in 
CRF2 knockout mice, indicating actions on other receptors (Zorrilla et 
al, 2013b). 
More recent studies demonstrated a role of CRF1 receptors in 
stress-induced reinstatement of cocaine seeking. Blacktop et al (2011) 
showed that VTA injections of the CRF1 receptor antagonists 
antalarmin or CP-376395 but not the CRF2 receptor antagonists 
astressin-2B or antisauvagine-30 decrease footshock-induced 
reinstatement of cocaine seeking in rats. Additionally, VTA injections of 
the CRF1 receptor agonist cortagine but not the CRF2 receptor agonist 
rat urocortin II mimic the effect of footshock stress on reinstatement. 
Chen et al (2014a) showed that local viral-mediated knockdown of VTA 
CRF1 receptors decreases food deprivation stress-induced 
reinstatement of cocaine seeking in mice. Vranjkovic et al (2014) also 
showed that injections of the beta-2 adrenoceptor antagonist ICI-
188,551 into the BNST in one hemisphere and the CRF1 receptor 
antagonist antalarmin into the VTA of the contralateral hemisphere 
decrease footshock-induced reinstatement of cocaine seeking. These 
data suggest a potential role of the CRF projection from BNST to VTA 
(Rodaros et al, 2007), which is activated by noradrenergic projections 
to BNST (Aston-Jones et al, 1999), in stress-induced reinstatement of 
cocaine seeking. In this regard, the BNST projection to VTA is also 
activated during swim stress-induced reinstatement of cocaine CPP in 
mice, as assessed by double labeling of the activity marker Fos with 
the retrograde tracer fluorogold gold (injected in VTA) in ventral BNST 
(Briand et al, 2010). 
Two recent studies by Kauer, Pierce and colleagues demonstrate 
a role of kappa/dynorphin signaling in VTA in cold swim stress-induced 
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reinstatement of cocaine seeking in rats (Graziane et al, 2013; Polter 
et al, 2014). In this stress reinstatement procedure, short (4–5 min) 
exposure to cold swim reinstates cocaine seeking 24 h later (Conrad et 
al, 2010). These studies were inspired by earlier studies on the 
regulation of VTA dopamine transmission by local kappa/dynorphin 
signaling (Ford et al, 2007; Margolis et al, 2003) and the findings that 
systemic injections of KOR antagonists decrease stress-induced drug 
seeking in rats and stress-induced reinstatement of drug CPP in mice 
(Tables 2 and and3)3) (Beardsley et al, 2005; Redila and Chavkin, 
2008). In the first study, Graziane et al (2013) showed that systemic 
injections of the KOR antagonist Nor-BNI rescue swim stress-induced 
abolishment of long-term potentiation (LTP) at GABAergic synapses on 
VTA dopaminergic neurons. Next, they showed that VTA injections of 
Nor-BNI decrease stress-induced reinstatement of cocaine seeking. In 
the second study, Polter et al (2014) showed that acute exposure to 
swim stress blocks normal LTP at GABAergic synapses on VTA 
dopaminergic neurons for up to 5 days, an effect dependent on KOR, 
and that surprisingly, systemic injections of Nor-BNI several hours 
after swim stress exposure also decrease the stressor's effect on 
reinstatement 24 h later. 
Summary. The studies reviewed above indicate that footshock stress-
induced activation of CRF and glutamate transmission in VTA is critical 
for the stressor's effect on reinstatement of drug seeking. A recent 
study by Vranjkovic et al (2014) further suggests that glutamatergic 
(Georges and Aston-Jones, 2002) and/or CRF (Rodaros et al, 2007) 
projections from BNST to VTA are the source of this activation. There 
is also evidence that KOR-mediated stress-induced alterations in 
GABAergic transmission in VTA have a critical role in the effect of cold 
swim stress on reinstatement of cocaine seeking. 
Dopamine and glutamate in NAc, mPFC, and OFC. Studies using 
intracranial injections of different dopamine receptor antagonists have 
demonstrated an important role of dopamine transmission in dorsal 
mPFC (prelimbic area) and OFC in stress-induced reinstatement of 
cocaine seeking. Capriles et al (2003) showed that dorsal (but not 
ventral or infralimbic area) mPFC and OFC injections of the D1-family 
receptor antagonist SCH23390 but not the D2-family receptor 
antagonist raclopride decrease footshock-induced reinstatement of 
cocaine seeking. McFarland et al (2004) showed that dorsal mPFC 
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injections of the mixed dopamine receptor antagonist flupenthixol 
decrease this reinstatement. Sanchez et al (2003) showed that 
SCH23390 injections into dorsal mPFC decrease restraint stress-
induced reinstatement of cocaine CPP. Dorsal mPFC dopamine and 
neuronal activity in this brain area also have a role in yohimbine-
induced reinstatement of palatable food seeking in male and female 
rats (Calu et al, 2013; Cifani et al, 2012; Nair et al, 2011) and acute 
food deprivation-induced reinstatement of heroin seeking (Tobin et al, 
2013). As VTA dopamine neurons project to mPFC and OFC (Moore 
and Bloom, 1979), the results from the studies reviewed above 
indicate that stress-induced activation of the dopaminergic projections 
from VTA to mPFC (Thierry et al, 1976) and OFC is critical for stress-
induced reinstatement. This activation involves D1-family receptors 
which, in the mPFC, are expressed on pyramidal cells where they 
promote excitability primarily by increasing NMDA receptor-mediated 
effects (Lewis and O'Donnell, 2000; Seamans et al, 2001). 
McFarland et al (2004) provided additional evidence that the 
circuit controlling footshock-induced reinstatement of cocaine seeking 
includes the dopaminergic projection from VTA to dorsal mPFC 
(prelimbic area), and also provided evidence that the glutamatergic 
projection from dorsal mPFC to NAc core (Sesack et al, 1989) and 
potentially the GABAergic projection from NAc shell to VTA (Zahm et 
al, 2001) (the ‘direct' striatal pathway) have a role in this 
reinstatement. They showed that (1) reversible inactivation of dorsal 
mPFC decreases both footshock-induced reinstatement and glutamate 
release in NAc core, (2) reversible inactivation of NAc shell and core, 
and as mentioned above the VTA, decreases this reinstatement, and 
(3) that reversible inactivation of NAc shell also decreases stress-
induced dopamine release in dorsal mPFC. These authors also showed 
that reversible inactivation of the ventral pallidum, a main output 
region of the striatal indirect pathway (Gerfen, 1992), decreases 
footshock-induced reinstatement. This circuit scheme, however, is 
speculative in the absence of more direct evidence from studies using 
classical anatomical asymmetrical disconnection procedures (Setlow et 
al, 2002) or more recent projection-specific inhibition using 
optogenetic (Stefanik et al, 2013) or chemogenetic (Mahler et al, 
2014) methods. 
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Evidence for a role of NAc dopamine in stress-induced 
reinstatement is somewhat mixed. Shaham and Stewart (1995) 
showed that footshock-induced reinstatement of heroin seeking is 
associated with increased dopamine levels in NAc. In contrast, 
McFarland et al (2004) showed that footshock-induced reinstatement 
of cocaine seeking is not associated with increased dopamine release 
in NAc and that flupenthixol injections into NAc core have no effect on 
this reinstatement. However, Xi et al (2004) showed that injections of 
the preferential D3 receptor antagonist SB-277011A into NAc 
(injections targeted primarily NAc shell) decrease footshock-induced 
reinstatement of cocaine seeking. Additionally, Tobin et al (2013) 
showed that SCH23390 injections into NAc shell but not core decrease 
food deprivation-induced reinstatement of heroin seeking. Thus, one 
possible account of these potentially discrepant results is that NAc 
shell but not core dopamine is critical for stress-induced reinstatement 
of drug seeking. 
Finally, a very recent study by Wheeler and colleagues suggests 
that at least for one stressor, a bitter quinine solution, reinstatement 
of cocaine seeking is associated with decreased tonic NAc dopamine 
levels, as assessed by in vivo voltammetry (Twining et al, 2015). They 
showed that in cocaine-experienced rats, exposure to quinine 
reinstates cocaine seeking, and that in drug-naïve rats, the same 
manipulation decreases tonic dopamine levels in NAc. Both of these 
effects were reversed by blockade of VTA CRF1 receptors. Together, 
with the previous results reviewed above, the results from this study 
suggest that both increases and decreases in NAc dopamine can have 
a role in stress-induced drug seeking. 
Summary. D1 receptor-mediated dopamine transmission in dorsal 
mPFC and the glutamatergic projection from this brain area to NAc 
core are critical for stress-induced reinstatement of cocaine seeking. 
This reinstatement also likely involves activation of the NAc GABAergic 
projections to VTA (the direct pathway) and ventral pallidum (the 
indirect pathway), as well as increased dopamine transmission in NAc 
shell. A recent study using intraoral delivery of quinine solution as the 
stressor suggests that stress-induced reinstatement can also be 
triggered by decreases in NAc dopamine tone. 
Median and Dorsal Raphe Nuclei 
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Many studies over the last several decades have implicated 
central serotonin in stress responses (Chaouloff, 1993; Maier, 1984; 
Maier and Watkins, 2005; Stone, 1983). This literature has led to 
studies on the role of serotonin in the two main cell body regions of 
brain serotonergic neurons—median raphe nucleus (MRN) and dorsal 
raphe nucleus (DRN) (Hale and Lowry, 2011; Vertes, 1991; Vertes et 
al, 1999)—in stress-induced reinstatement of alcohol seeking in rats 
and stress-induced reinstatement of cocaine and morphine CPP. 
Role of MRN in stress-induced reinstatement of alcohol seeking. 
Le et al (1999) showed that systemic injections of the serotonin 
reuptake blocker fluoxetine, which increases brain serotonin levels, 
decrease footshock-induced reinstatement of alcohol seeking, 
indicating that serotonin negatively regulates this reinstatement. This 
negative regulation involves the MRN. Local injections of the selective 
5-HT1a autoreceptor agonist 8-OH-DPAT, which decrease serotonin 
cell firing and release (Mongeau et al, 1997), mimic the effect of 
intermittent footshock on reinstatement (Le et al, 2002). Additionally, 
these authors showed that MRN injections of the non-selective CRF 
receptor antagonist D-Phe CRF12–41 decrease footshock-induced 
reinstatement of alcohol seeking while MRN injections of very low 
doses of CRF (10 ng) partially mimic the stressor's effect on 
reinstatement. A physiological mechanism that connects the similar 
effects of 8-OH-DPAT and low-dose CRF injections in MRN on 
reinstatement is that low CRF doses, like 8-OH-DPAT, decrease 
serotonin cell firing and release (Kirby et al, 2000; Price et al, 1998). 
However, to date, this effect has only been reported for DRN but not 
for MRN neurons. Finally, Le et al (2008) showed that reversible 
inactivation of the MRN with the GABAa agonist muscimol reinstates 
alcohol seeking. However, the relevance of this observation to 
serotonin's role in stress-induced reinstatement is questionable 
because this effect is not reversed by lesions of serotonin-containing 
neurons in the brain. 
Role of DRN in stress-induced reinstatement of morphine and 
cocaine CPP. Results from CPP reinstatement studies from the Kirby 
and Chavkin laboratories implicate the DRN serotonergic cell body 
region in stress-induced reinstatement. Staub et al (2012) showed 
that swim stress-induced reinstatement of morphine CPP is associated 
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with increased GABAergic postsynaptic neuronal activity that leads to 
inhibition of DRN serotonin neurons, and that this inhibitory effect 
involves local CRF signaling. In a follow-up study, Li et al (2013) 
showed that increasing GABAergic inhibitory transmission by DRN 
muscimol injections reinstates morphine CPP while inhibition of 
GABAergic neurons by bicuculline (a GABAa receptor antagonist) 
decreases swim stress-induced reinstatement. 
There is also evidence for a role of kappa/dynorphin signaling in 
DRN in stress-induced reinstatement of cocaine CPP in mice. Land et al 
(2009) showed that DRN injections of the KOR antagonist Nor-BNI 
decrease social stress-induced reinstatement of cocaine CPP in mice. 
Their results from experiments examining the role of kappa/dynorphin 
in DRN in aversive behavior also suggest that the serotonergic 
projection from DRN to NAc likely has a role in the local inhibitory 
effect of Nor-BNI in DRN on stress-induced reinstatement of cocaine 
CPP; however, this possibility was not empirically tested. In a 
subsequent study, the Chavkin laboratory showed that KOR-mediated 
social stress-induced activation of p38 mitogen-activated protein 
kinase (MAPK) in DRN serotonergic neurons has a critical role in 
stress-induced reinstatement of cocaine CPP (Bruchas et al, 2011). In 
this study, the authors first showed that exposure to social defeat 
stress, which induces reinstatement of cocaine seeking, activates 
p38MAPK in DRN, and that this effect is reversed by Nor-BNI and is 
not observed in KOR knockout mice. They then showed that viral-
mediated selective deletion of p38MAPK in DRN serotonin neurons 
decreases social stress-induced reinstatement of cocaine CPP. 
Summary. The results of the studies reviewed above indicate an 
important role for an interaction between CRF and serotonin in MRN in 
footshock stress-induced reinstatement of alcohol seeking. There is 
also evidence for a role of DRN serotonergic neurons, which involves 
both CRF and kappa/dynorphin. A question for future research is which 
serotonergic projection areas contribute to the distinct roles of MRN 
and DRN in stress-induced reinstatement in the operant model and the 
CPP model (Figure 3). 
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Figure 3. The circuitry of stress-induced reinstatement of drug seeking. The figure 
depicts brain regions, neuronal projections, and neurotransmitters implicated in 
stress-induced reinstatement of drug seeking and stress-induced reinstatement of 
drug CPP (see text for details). Filled lines represent established projections and 
dashed lines represent putative projections. Abbreviations: CeA, central nucleus of the 
amygdala; DRN, dorsal raphe nucleus, MRN, median raphe nucleus; mPFC, medial 
prefrontal cortex; NAc: nucleus accumbens; OFC, orbitofrontal cortex; vBNST, ventral 
BNST; VP, ventral pallidum; VTA, ventral tegmental area. 
 
Translational Human Research 
In this section, we describe results from several human 
laboratory studies and two double-blind clinical trials in which 
pharmacological agents that decrease stress-induced reinstatement of 
drug seeking were tested for their effects on drug craving and relapse 
in humans. These include the alpha-2 adrenoceptor agonists, 
clonidine, guanfacine, and lofexidine, the alpha-1 adrenoceptor 
antagonist, prazosin, and the CRF1 receptor antagonist, pexacerfont. 
Figures 4 and and55 show comparative data on the effect of alpha-2 
adrenoceptor agonists and CRF1 receptor antagonists on stress-
induced reinstatement of drug seeking in rats and stress-induced 
craving and time to first lapse in humans. 
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Figure 4. Effects of alpha-2 adrenoceptor agonists on stress-induced reinstatement in 
rats and stress-induced craving in humans. (a) Rat studies: Data are mean±SEM non-
reinforced active lever presses after exposure to intermittent footshock or no shock 
immediately prior to the reinstatement tests in rats with a history of heroin, cocaine, 
speedball (a heroin-cocaine combination), or alcohol self-administration. The session 
duration was 3 h for heroin, cocaine, and speedball, and 1 h for alcohol. The 
intermittent footshock duration was 15 min for heroin, cocaine, and speedball, and 
10 min for alcohol. Clonidine and lofexidine were injected 25–45 min before 
intermittent footshock exposure. (b) Human studies: Left side: Data are mean±SEM 
subjective craving responses assessed on an ordinal Likert scale in opiate users 
(maintained on naltrexone) or cocaine users who were pretreated with lofexidine or 
clonidine, respectively, or placebo and exposed to a guided imagery stress or no stress 
(neutral guided imagery) manipulation. Right side: days to first lapse in human 
subjects that received chronic placebo or clonidine in a clinical trial. Data were 
redrawn from Erb et al (2000), Highfield et al (2001), Jobes et al (2011), Kowalczyk et 
al (2014), Le et al (2005), Shaham et al (2000b), and Sinha et al (2007). *Different 
from the vehicle (0 dose) in the stress condition or different from the placebo 
condition, p<0.05. 
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Figure 5. Effects of CRF1 receptor antagonists on stress-induced reinstatement in rats 
and stress-induced craving in humans. (a) Rat studies: Data are mean±SEM non-
reinforced active lever presses after exposure to intermittent footshock or no shock 
immediately prior to the reinstatement tests in rats with a history of heroin, cocaine, 
or alcohol self-administration. The session duration was 3 h for heroin and cocaine, 
and 1 h for alcohol. The intermittent footshock duration was 15 min for heroin and 
10 min for cocaine and alcohol. The CRF1 receptor antagonist CP-154,526 was injected 
30 min before intermittent footshock exposure. (b) Human study: Data are mean±SEM 
subjective craving responses assessed on an ordinal Likert scale in alcohol users who 
were pretreated with the CRF1 receptor antagonist pexacerfont and exposed to a 
guided imagery stress or no stress (neutral guided imagery) manipulation. Data were 
redrawn from Kwako et al (2015), Le et al (2000) and Shaham et al (1998). *Different 
from the vehicle (0 dose) in the stress condition, p<0.05. 
Human Laboratory Studies 
In 1999, Sinha and colleagues introduced a laboratory model to 
determine, in a cause-effect manner, the effect of stress on drug 
craving under controlled laboratory conditions (Sinha, 2001; Sinha et 
al, 1999). They and other investigators showed that certain stressors, 
including guided imagery stress, the Trier Social Stress Task, and 
systemic CRF injections induce physiological (eg, increased cortisol 
release) and psychological (eg, increased anxiety) stress responses 
and increase self-reports of drug craving (Back et al, 2010; Sinha, 
2009; Sinha et al, 1999). From the perspective of drug relapse, an 
important finding from these studies is that physiological and 
psychological (including drug craving) stress responses in the 
laboratory predict, to some degree, subsequent drug relapse (Back et 
al, 2010; Higley et al, 2011; Sinha et al, 2006, 2011a). 
Alpha-2 adrenoceptor agonists. In several studies, investigators 
determined the effects of alpha-2 adrenoceptor agonists on stress- and 
cue-induced craving in opiate, cocaine, heroin, and nicotine (smokers) 
users. In an initial preliminary study, Sinha et al (2007) showed that in 
opiate users maintained on naltrexone, lofexidine treatment 
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(2.4 mg/day) decreases both stress- and cue-induced opiate craving. 
Similar findings were observed in a larger sample study with cocaine 
users in which Jobes et al (2011) showed that clonidine (0.1 or 
0.2 mg) administration decreases stress- and cue-induced cocaine 
craving (Figure 3). 
In another study, Fox et al (2012) determined the effects of 
guanfacine (up to 3 mg/day) on stress-, cue-, and stress+cue-induced 
drug craving in cocaine-dependent individuals who also use alcohol 
and nicotine (smokers). They showed that guanfacine decreases 
stress- and cue-induced nicotine craving. Guanfacine also modestly 
decreased cue-induced cocaine craving, anxiety, and arousal, but not 
stress-induced craving. However, the latter negative finding may 
reflect a floor effect, because the stress manipulation caused a very 
weak craving response in the placebo group. 
More recently, McKee et al (2014) showed that in human 
smokers guanfacine treatment (3 mg/day) decreases both stress-
induced drug craving and stress-induced smoking in the laboratory. In 
another study, Fox et al (2014) examined the effect of guanfacine (2 
or 3 mg/day) on stress-, cue, and stress+cue-induced craving in male 
and female cocaine users who also use alcohol and nicotine (smokers). 
A surprising finding in this study was that guanfacine selectively 
decreased cocaine craving, alcohol craving, anxiety, and negative 
emotion following exposure to all three experimental conditions in 
females but not in males. In contrast, guanfacine decreased stress and 
cue-induced nicotine craving in both males and females. Finally, in a 
very recent study Moran-Santa Maria et al (2015a) showed that in 
cocaine users acute administration of guanfacine (2 mg) has no effect 
on cocaine craving in response to stress, cue, or stress+cue. In 
interpreting these data, two pharmacological factors should be 
considered. The first is that, unlike the previous guanfacine studies of 
Sinha and colleagues in which guanfacine was given chronically for 
several weeks, in the Moran-Santa Maria et al (2015a) study, the drug 
was given acutely. The second is that the data of Sinha and colleagues 
suggest that the minimal effective dose of guanfacine in the laboratory 
studies is ~3 mg, which is higher than the dose used in Moran-Santa 
Maria et al study. 
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Findings from three other human laboratory studies in which 
yohimbine was used to induce drug craving and seeking provide 
additional support to the translational value of stress-induced 
reinstatement studies in laboratory animals. In these studies, doses of 
yohimbine that induced physiological and psychological stress 
responses increased alcohol craving (Umhau et al, 2011), potentiated 
cue-induced cocaine craving (an effect that was more pronounced in 
females), and increased opiate seeking in a choice-based 
(hydromorphone vs money) progressive ratio task (Greenwald et al, 
2013). Thus, despite the interpretation issues related to yohimbine's 
effects in rat reinstatement studies (Box 2), in humans, the drug 
induces an aversive stress-like state of which one manifestation is 
increased drug craving and seeking. 
Finally, as discussed elsewhere (Bossert et al, 2013), an 
unexpected finding in the human studies was that alpha-2 
adrenoceptor agonists decreased both stress- and cue-induced drug 
craving. This was unexpected because in rat studies the alpha-2 
adrenoceptor agonists selectively decreased footshock stress-induced 
reinstatement but not drug priming- or cue-induced reinstatement 
(Erb et al, 2000; Highfield et al, 2001), but see Smith and Aston-Jones 
(2011) for different results. A possible account for these different 
findings is that in rats cue exposure primarily induces an appetitive 
motivational state (See, 2005) while in humans, cue exposure also 
induces stress-like physiological and psychological states that are 
similar to those induced by stress exposure (Sinha et al, 1999, 2000). 
Alpha-1 adrenoceptor and CRF1 receptor antagonists. Two studies 
determined the effects of the alpha-1 adrenoceptor antagonist 
prazosin or the CRF1 receptor antagonist pexacerfont on stress- and 
cue-induced alcohol craving. Fox et al (2012) showed that in alcohol 
users prazosin (16 mg/day) decreases stress-induced craving and 
negative emotions. Prazosin also decreased cue-induced negative 
emotion self-reports, but had no effect on cue-induced craving. The 
negative data might be due to a floor effect, because of a weak cue-
induced craving in the placebo group. 
Most recently, Kwako et al (2015) determined the effects of oral 
pexacerfont (300 mg/day for 7 days and 100 mg/day for 23 days) on 
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stress- and cue-induced alcohol craving in ‘anxious' alcohol-dependent 
subjects. This study was inspired by the large and remarkably 
consistent preclinical literature on the effect of CRF receptor 
antagonists on escalation of drug intake, stress-like physiological and 
psychological withdrawal symptoms, and stress-induced reinstatement 
of drug seeking across drug classes (Heilig and Koob, 2007; Koob, 
2008; Shalev et al, 2010; Zorrilla et al, 2013a). In sharp contrast to 
the preclinical data, pexacerfont treatment had no effect on stress- or 
cue-induced alcohol craving, emotional responses, or anxiety (Figure 
4). Pexacerfont also had no effect on neural responses (fMRI) to 
alcohol-related or affective-related cues. 
Clinical Trials 
The data from the laboratory studies described above provide 
evidence for the human ‘translational' value of the stress-induced 
reinstatement model. However, from a perspective of human drug 
relapse, a critical test for the predictive validity of the model is 
whether medications identified in the rat model show efficacy in the 
drug user's environment (Epstein et al, 2006). Kowalczyk et al (2014) 
recently determined in heroin users whether the clinical efficacy of 
buprenorphine would be enhanced by clonidine. In this relapse 
prevention study, the subjects first received contingency management 
to facilitate initial abstinence. Subjects who successfully maintained 
abstinence were randomized to receive clonidine (0.1 mg for 1 week, 
0.2 mg for the next week, and 0.3 mg for the rest of the study, n=61) 
or placebo (n=57) for 14 weeks. The main dependent measures were 
time to lapse (defined as any opiate positive or missed urines) and 
time to relapse (defined as any consecutive lapses), as well as 
baseline craving, and stress- and cue-induced craving in the subjects' 
home environment, as assessed by real-time ecological momentary 
assessment (EMA) (Epstein et al, 2009). The main findings of the 
study were that clonidine treatment increased the time to lapse (from 
25 to 35 days) (Figure 4) and decreased baseline craving and stress-
induced craving. In contrast, clonidine had no effect on relapse rates 
once a lapse had occurred. 
In the context of our review, a study of Krupitsky et al (2013), 
which likely was not based on the stress-induced reinstatement studies 
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in the animal model, is also relevant. In this 6-month clinical trial, 
these authors determined whether guanfacine (1 mg/day) would 
decrease relapse rates in opiate users maintained on naltrexone. The 
main finding was that guanfacine had no effect on relapse rates but 
decreased self-reports of stress and craving. While the study included 
a large number of subjects (n=75 per group) and was well designed, a 
potential methodological issue was the use of a low guanfacine dose 
(1 mg). The studies described in section ‘Human laboratory studies' 
suggest that the effective dose of guanfacine in the laboratory studies 
is ~3 mg (Fox et al, 2014; McKee et al, 2014). 
Summary 
The results of the human studies with alpha-2 adrenoceptor 
agonists and prazosin appear to support the translational utility of the 
stress-induced reinstatement model. However, unlike the uniform 
effects of these agonists on stress-induced reinstatement in the rat 
model, the effects in the human studies are more variable, and some 
of the human studies reported negative results (Krupitsky et al, 2013; 
Moran-Santa Maria et al, 2015a), possibly due to the use of doses that 
were lower than those used in the studies that report positive effects. 
The human studies also suggest potential sex differences in the 
efficacy of alpha-2 adrenoceptor agonists (Fox et al, 2014), a factor 
that has not been considered in the preclinical studies. What might 
account for the more heterogeneous/variable results in the clinical 
preclinical studies? 
We propose that four factors might be particularly important. 
The first is the fact that rat or mouse studies are invariably performed 
using highly homogenous subjects of the same or similar age, sex, 
drug exposure duration, and in many cases likely from a limited 
number of litters (and therefore a homogenous genetic background). 
In contrast, the human studies are performed with a highly 
heterogeneous subject population of different ages, duration of drug 
use, race, and also includes both sexes. The second factor is the more 
flexible nature of studies using animal models, which allows 
investigators to adjust both experimental parameters, including drug 
doses, to determine the effects of pharmacological agents on 
reinstatement under more than one experimental set-up. In contrast, 
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human studies are typically performed double-blind from start to end, 
which increases statistical power but may result in negative data due 
to two main sources that have a significant role in the studies 
reviewed above: drug doses that were likely too low and experimental 
manipulations (stress- or cue-induced reinstatement) that in some 
studies had minimal effect on craving, making it difficult to detect a 
reliable effect of the medication. Third, a significant issue in assessing 
the efficacy of medications to treat drug addiction is compliance 
(Weiss, 2004), an issue that likely also played a role in the studies 
reviewed above. Fourth, the different types of stressors used in the 
preclinical studies (exposure to a physical aversive stimulus such as 
footshock, restraint, or cold water) vs the stressors used in the clinical 
studies (exposure to psychological stressors like stress imagery or the 
Trier Social Stress Task) is an issue to consider in ‘translational' 
studies on stress-induced reinstatement of drug seeking in which 
different results are observed in human studies vs. animal models. 
Finally, the negative results with pexacerfont (Kwako et al, 
2015) indicate that it is unrealistic to expect that all potential 
medications identified in animal models of psychiatric disorders, 
including the stress-induced reinstatement model, will readily translate 
to the human condition. However, these negative data are particularly 
disappointing because, as mentioned above, they are based on 
unparalleled convergence from multiple animal models of drug 
addiction and results that were independently demonstrated in 
multiple laboratories using different drugs of abuse under different 
experimental conditions (Heilig and Koob, 2007; Koob, 2008; Sarnyai 
et al, 2001; Shalev et al, 2010). 
Conclusions and Future Directions 
The demonstration that a brief exposure to uncontrollable and 
unpredictable intermittent footshock stress reinstates heroin seeking in 
rats (Shaham and Stewart, 1995) has stimulated research by many 
preclinical investigators on behavioral and neuropharmacological 
mechanisms of stress-induced reinstatement of drug seeking and CPP. 
The preclinical model of stress-induced reinstatement and the 
demonstration that stress can provoke drug craving under controlled 
experimental conditions (Sinha et al, 1999) have also stimulated 
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translational research to identify potential medications that specifically 
target stress-induced craving and relapse in humans. In this review, 
we summarized this field of research to consolidate the current state 
of knowledge within a single review. The results from the studies 
reviewed suggest at least four future lines of investigation. 
The first is the investigation of the synaptic and cellular 
mechanisms of stress-induced reinstatement. Several studies have 
explored this question for swim stress-induced reinstatement of 
cocaine seeking in rats (Chirila et al, 2014; Kreibich and Blendy, 2004; 
Polter et al, 2014) and social defeat-induced reinstatement of cocaine 
CPP in mice (Bruchas et al, 2010, 2011; Land et al, 2009). At present, 
however, the synaptic and cellular mechanisms of stress-induced 
reinstatement are largely unknown. 
The second is the investigation of circuitry mechanisms of 
stress-induced reinstatement, using neuroscience methods that go 
beyond classical neuropharmacological and neuroanatomical methods. 
In the ‘relapse/reinstatement' field, investigators recently have begun 
to incorporate modern chemogenetic (Bossert et al, 2011; Cruz et al, 
2014; Fanous et al, 2012; Mahler et al, 2014) and optogenetic (Lee et 
al, 2013; Ma et al, 2014; Stefanik et al, 2013) methods to study brain 
circuits of context-, cue-, and drug priming-induced reinstatement of 
drug seeking, but these methods have not yet been used for stress-
induced reinstatement. 
The third is the study of sex differences in stress-induced 
reinstatement of drug seeking. In this regard, footshock stress-
induced reinstatement of drug seeking is observed in both male and 
female rats (Shaham and Stewart, 1995). Additionally, recent studies 
on sex differences and the role of ovarian hormones in stress-induced 
reinstatement have used yohimbine as a stressor and the results are 
mixed. Two studies showed that yohimbine effect on reinstatement of 
cocaine and methamphetamine seeking is somewhat stronger in 
female rats than in male rats (Anker and Carroll, 2010a; Cox et al, 
2013). However, other studies have shown neither sex differences nor 
a role of ovarian hormones in yohimbine-induced reinstatement of 
nicotine or palatable food seeking (Cifani et al, 2012; Feltenstein et al, 
2012; Pickens et al, 2012). A question for future research is whether 
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sex differences would be observed in the mechanisms that mediate 
stress-induced reinstatement. 
Finally, during human abstinence, stress exposure often occurs 
in the presence of contexts and cues previously associated with drug 
use and the drug itself in the case of an initial lapse (Epstein et al, 
2009). Human laboratory studies also indicate that stress can 
potentiate cue-induced drug craving (Fox et al, 2014; George et al, 
2008; Moran-Santa Maria et al, 2015b). Additionally, studies using the 
reinstatement model demonstrate that stress exposure potentiates the 
response to both cues (Buffalari and See, 2009; Liu and Weiss, 2002b) 
and drug priming injections (Graf et al, 2013). Thus, from a 
translational perspective, mechanistic studies on stress-induced 
potentiation of the response to drug cues or contexts after extinction 
or without prior extinction may lead to the identification of new targets 
for developing medications for relapse prevention. 
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